Report Detail

Pharma & Healthcare Global 3D Printed Drugs Market Research Report 2019

  • RnM3108928
  • |
  • 12 March, 2019
  • |
  • Global
  • |
  • 94 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

3D Printed Drugs Market are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. 
Spritam is the only 3D printed drug which has received FDA approval. This drug was first available in the market in 2016, and can be used to treat epilepsy. 

The global 3D Printed Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on 3D Printed Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall 3D Printed Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Aprecia Pharmaceuticals
GlaxoSmithKline Plc
Hewlett Packard Caribe
BV
LLC
3D Printer Drug Machine
FabRx Ltd
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Spritam
Others

Segment by Application
Children
Elderly
Others


Table of Contents

    Executive Summary

      1 3D Printed Drugs Market Overview

      • 1.1 Product Overview and Scope of 3D Printed Drugs
      • 1.2 3D Printed Drugs Segment by Type
        • 1.2.1 Global 3D Printed Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Spritam
        • 1.2.3 Others
      • 1.3 3D Printed Drugs Segment by Application
        • 1.3.1 3D Printed Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Children
        • 1.3.3 Elderly
        • 1.3.4 Others
      • 1.4 Global 3D Printed Drugs Market by Region
        • 1.4.1 Global 3D Printed Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global 3D Printed Drugs Market Size
        • 1.5.1 Global 3D Printed Drugs Revenue (2014-2025)
        • 1.5.2 Global 3D Printed Drugs Production (2014-2025)

      2 Global 3D Printed Drugs Market Competition by Manufacturers

      • 2.1 Global 3D Printed Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global 3D Printed Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global 3D Printed Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers 3D Printed Drugs Production Sites, Area Served, Product Types
      • 2.5 3D Printed Drugs Market Competitive Situation and Trends
        • 2.5.1 3D Printed Drugs Market Concentration Rate
        • 2.5.2 3D Printed Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global 3D Printed Drugs Production Market Share by Regions

      • 3.1 Global 3D Printed Drugs Production Market Share by Regions
      • 3.2 Global 3D Printed Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global 3D Printed Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America 3D Printed Drugs Production
        • 3.4.1 North America 3D Printed Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America 3D Printed Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe 3D Printed Drugs Production
        • 3.5.1 Europe 3D Printed Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe 3D Printed Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China 3D Printed Drugs Production (2014-2019)
        • 3.6.1 China 3D Printed Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China 3D Printed Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan 3D Printed Drugs Production (2014-2019)
        • 3.7.1 Japan 3D Printed Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan 3D Printed Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global 3D Printed Drugs Consumption by Regions

      • 4.1 Global 3D Printed Drugs Consumption by Regions
      • 4.2 North America 3D Printed Drugs Consumption (2014-2019)
      • 4.3 Europe 3D Printed Drugs Consumption (2014-2019)
      • 4.4 China 3D Printed Drugs Consumption (2014-2019)
      • 4.5 Japan 3D Printed Drugs Consumption (2014-2019)

      5 Global 3D Printed Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global 3D Printed Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global 3D Printed Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global 3D Printed Drugs Price by Type (2014-2019)
      • 5.4 Global 3D Printed Drugs Production Growth by Type (2014-2019)

      6 Global 3D Printed Drugs Market Analysis by Applications

      • 6.1 Global 3D Printed Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global 3D Printed Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in 3D Printed Drugs Business

      • 7.1 Aprecia Pharmaceuticals
        • 7.1.1 Aprecia Pharmaceuticals 3D Printed Drugs Production Sites and Area Served
        • 7.1.2 3D Printed Drugs Product Introduction, Application and Specification
        • 7.1.3 Aprecia Pharmaceuticals 3D Printed Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 GlaxoSmithKline Plc
        • 7.2.1 GlaxoSmithKline Plc 3D Printed Drugs Production Sites and Area Served
        • 7.2.2 3D Printed Drugs Product Introduction, Application and Specification
        • 7.2.3 GlaxoSmithKline Plc 3D Printed Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Hewlett Packard Caribe
        • 7.3.1 Hewlett Packard Caribe 3D Printed Drugs Production Sites and Area Served
        • 7.3.2 3D Printed Drugs Product Introduction, Application and Specification
        • 7.3.3 Hewlett Packard Caribe 3D Printed Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 BV
        • 7.4.1 BV 3D Printed Drugs Production Sites and Area Served
        • 7.4.2 3D Printed Drugs Product Introduction, Application and Specification
        • 7.4.3 BV 3D Printed Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 LLC
        • 7.5.1 LLC 3D Printed Drugs Production Sites and Area Served
        • 7.5.2 3D Printed Drugs Product Introduction, Application and Specification
        • 7.5.3 LLC 3D Printed Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 3D Printer Drug Machine
        • 7.6.1 3D Printer Drug Machine 3D Printed Drugs Production Sites and Area Served
        • 7.6.2 3D Printed Drugs Product Introduction, Application and Specification
        • 7.6.3 3D Printer Drug Machine 3D Printed Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 FabRx Ltd
        • 7.7.1 FabRx Ltd 3D Printed Drugs Production Sites and Area Served
        • 7.7.2 3D Printed Drugs Product Introduction, Application and Specification
        • 7.7.3 FabRx Ltd 3D Printed Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served

      8 3D Printed Drugs Manufacturing Cost Analysis

      • 8.1 3D Printed Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of 3D Printed Drugs
      • 8.4 3D Printed Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 3D Printed Drugs Distributors List
      • 9.3 3D Printed Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global 3D Printed Drugs Market Forecast

      • 11.1 Global 3D Printed Drugs Production, Revenue Forecast
        • 11.1.1 Global 3D Printed Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global 3D Printed Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global 3D Printed Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global 3D Printed Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America 3D Printed Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe 3D Printed Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China 3D Printed Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan 3D Printed Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global 3D Printed Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America 3D Printed Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe 3D Printed Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China 3D Printed Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan 3D Printed Drugs Consumption Forecast (2019-2025)
      • 11.4 Global 3D Printed Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global 3D Printed Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on 3D Printed Drugs. Industry analysis & Market Report on 3D Printed Drugs is a syndicated market report, published as Global 3D Printed Drugs Market Research Report 2019. It is complete Research Study and Industry Analysis of 3D Printed Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,900.00
        $4,350.00
        $5,800.00
        2,296.80
        3,445.20
        4,593.60
        2,679.60
        4,019.40
        5,359.20
        438,741.00
        658,111.50
        877,482.00
        241,773.00
        362,659.50
        483,546.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report